{"title":"心脏代谢健康的新维度:肠道微生物群、生态失调及其后果","authors":"Vinod Nikhra","doi":"10.19080/crdoj.2019.11.555805","DOIUrl":null,"url":null,"abstract":"The new dimension in cardio-metabolic health: Cardio-metabolic disorders (CMDs) encompass various disorders like there have evolved potential strategies for therapeutically targeting intestinal microbiota and microbial processes. The MTT appears to be a promising strategy to prevent and treat metabolic disorders as well as CVD. The most frequently used measures to manipulate the gut microbiota to reduce CV risk and CVD are therapeutic use of probiotics, prebiotics and certain nutraceuticals. The therapeutic intervention to repair microbial dysbiosis through fecal microbiota transplantation (FMT) appears to be a potential therapy for CVD and various metabolic disorders like metabolic syndrome, T2DM and obesity.","PeriodicalId":92021,"journal":{"name":"Current research in diabetes & obesity journal","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"The Novel Dimensions of Cardio-Metabolic Health: Gut Microbiota, Dysbiosis and its Fallouts\",\"authors\":\"Vinod Nikhra\",\"doi\":\"10.19080/crdoj.2019.11.555805\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The new dimension in cardio-metabolic health: Cardio-metabolic disorders (CMDs) encompass various disorders like there have evolved potential strategies for therapeutically targeting intestinal microbiota and microbial processes. The MTT appears to be a promising strategy to prevent and treat metabolic disorders as well as CVD. The most frequently used measures to manipulate the gut microbiota to reduce CV risk and CVD are therapeutic use of probiotics, prebiotics and certain nutraceuticals. The therapeutic intervention to repair microbial dysbiosis through fecal microbiota transplantation (FMT) appears to be a potential therapy for CVD and various metabolic disorders like metabolic syndrome, T2DM and obesity.\",\"PeriodicalId\":92021,\"journal\":{\"name\":\"Current research in diabetes & obesity journal\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-06-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current research in diabetes & obesity journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.19080/crdoj.2019.11.555805\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current research in diabetes & obesity journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19080/crdoj.2019.11.555805","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The Novel Dimensions of Cardio-Metabolic Health: Gut Microbiota, Dysbiosis and its Fallouts
The new dimension in cardio-metabolic health: Cardio-metabolic disorders (CMDs) encompass various disorders like there have evolved potential strategies for therapeutically targeting intestinal microbiota and microbial processes. The MTT appears to be a promising strategy to prevent and treat metabolic disorders as well as CVD. The most frequently used measures to manipulate the gut microbiota to reduce CV risk and CVD are therapeutic use of probiotics, prebiotics and certain nutraceuticals. The therapeutic intervention to repair microbial dysbiosis through fecal microbiota transplantation (FMT) appears to be a potential therapy for CVD and various metabolic disorders like metabolic syndrome, T2DM and obesity.